首页> 外国专利> NORMALIZATION METHOD DEVELOPMENT antithrombin III in the vascular wall in newborn calves with iron deficiency anemia

NORMALIZATION METHOD DEVELOPMENT antithrombin III in the vascular wall in newborn calves with iron deficiency anemia

机译:标准化方法新生儿缺铁性贫血犊牛血管壁中抗凝血酶III的发育

摘要

FIELD: veterinary medicine.;SUBSTANCE: ferroglucine 150 mg (2 ml) intramuscularly, twice with an interval of 4 days, crezacyne 5 mg/kg per day, including it into a watering scheme for 4 days, are used simultaneously, starting simultaneously with the first injection of ferroglucine, and gamavite intramuscularly once a day in the morning 0.05 ml/kg, starting simultaneously with ferroglucine and crezacyne.;EFFECT: use of the claimed invention enables to normalise the production of antithrombin III in the vascular wall in new-born calves with iron deficiency anaemia and to reduce deaths.;1 dwg, 1 tbl, 2 ex
机译:领域:兽药;物质:肌注铁镁葡萄糖150 mg(2 ml),两次,间隔4天,每天使用5 mg / kg的Crezacyne,并以4天的浇水方案同时使用,从每天一次,每天一次肌肉注射0.05mg / kg的铁镁葡萄糖胺和gamavite,同时与铁镁葡萄糖胺和crezacyne一起开始。;效果:使用要求保护的发明能够使新的血管壁中抗凝血酶III的产生正常化。出生的小牛患有缺铁性贫血并减少死亡。; 1 dwg,1 tbl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号